Literature DB >> 19192049

Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function.

Umesh S Deshmukh1, Seshagiri Rao Nandula, Pushpa-Rekha Thimmalapura, Yogesh M Scindia, Harini Bagavant.   

Abstract

BACKGROUND: Recent studies have demonstrated the expression of Toll-like receptor 3 (TLR3) in salivary glands and epithelial cell lines derived from Sjögren's syndrome (SS) patients. As viral infections are considered to be a trigger for SS, in this study we investigated whether in vivo engagement of TLR3 affects salivary gland function.
METHODS: Female New Zealand Black/WF1 mice were repeatedly injected with polyinosinic:polycytidylic acid [poly(I:C)]. TLR3 expression within submandibular glands was studied using immunohistochemistry. RNA levels of inflammatory cytokines in the submandibular glands were determined by real time polymerase chain reaction. Pilocarpine induced saliva volume was used as an index of glandular function.
RESULTS: Immunohistochemical analysis of submandibular glands showed TLR3 expression in epithelium of serous and mucous acini, granular convoluted tubules, and ducts. Poly(I:C) treatment rapidly up-regulated the mRNA levels of type I interferon (IFN) and inflammatory cytokines in the submandibular glands. One week after treatment, the saliva volumes in poly(I:C) treated mice were significantly reduced in comparison with the phosphate-buffered saline (PBS) treated mice. Hematoxylin and eosin staining showed that salivary gland histology was normal and lymphocytic foci were not detected. Glandular function recovered after poly(I:C) treatment was stopped.
CONCLUSIONS: Our results demonstrate that engagement of TLR3 within the salivary glands results in a rapid loss of glandular function. This phenomenon is associated with the production of type I IFN and inflammatory cytokines in the salivary glands. Restoration of glandular function suggests that for viral etiology of SS, a chronic infection of salivary glands might be necessary.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19192049      PMCID: PMC2763314          DOI: 10.1111/j.1600-0714.2008.00700.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  22 in total

1.  Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.

Authors:  D Zoukhri; C L Kublin
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

2.  Inhibition of salivary secretion by lipopolysaccharide: possible role of prostaglandins.

Authors:  A Lomniczi; C Mohn; A Faletti; A Franchi; S M McCann; V Rettori; J C Elverdin
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-08       Impact factor: 4.310

Review 3.  Sjogrens syndrome--the non-apoptotic model of glandular hypofunction.

Authors:  L J Dawson; P C Fox; P M Smith
Journal:  Rheumatology (Oxford)       Date:  2006-04-04       Impact factor: 7.580

4.  Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome.

Authors:  M P Spachidou; E Bourazopoulou; C I Maratheftis; E K Kapsogeorgou; H M Moutsopoulos; A G Tzioufas; M N Manoussakis
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

5.  Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients.

Authors:  S Steinfeld; E Cogan; L S King; P Agre; R Kiss; C Delporte
Journal:  Lab Invest       Date:  2001-02       Impact factor: 5.662

6.  Induction and immunohistology of autoimmune ovarian disease in cynomolgus macaques (Macaca fascicularis).

Authors:  Harini Bagavant; Colin Sharp; Barbara Kurth; Kenneth S K Tung
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

7.  Lipopolysaccharide-induced elevation and secretion of interleukin-1beta in the submandibular gland of male mice.

Authors:  Chenjuan Yao; Xuefei Li; Kwartarini Murdiastuti; Chisato Kosugi-Tanaka; Tetsuya Akamatsu; Norio Kanamori; Kazuo Hosoi
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

8.  Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjögren's syndrome.

Authors:  Yukiko Ohyama; Virginia A Carroll; Umesh Deshmukh; Felicia Gaskin; Michael G Brown; Shu Man Fu
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

9.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

10.  Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways.

Authors:  Marc Ittah; Corinne Miceli-Richard; Jacques-Eric Gottenberg; Jérémie Sellam; Pierre Eid; Pierre Lebon; Coralie Pallier; Christine Lepajolec; Xavier Mariette
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

View more
  42 in total

1.  Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.

Authors:  Dominika Nackiewicz; Paromita Dey; Barbara Szczerba; Saleh Mohammad; Jennifer L Kaplan; Coleen A McNamara; Umesh S Deshmukh; Harini Bagavant
Journal:  Nephron Exp Nephrol       Date:  2014-05-16

2.  Interaction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice.

Authors:  Barbara M Szczerba; Paulina Kaplonek; Nina Wolska; Anna Podsiadlowska; Paulina D Rybakowska; Paromita Dey; Astrid Rasmussen; Kiely Grundahl; Kimberly S Hefner; Donald U Stone; Stephen Young; David M Lewis; Lida Radfar; R Hal Scofield; Kathy L Sivils; Harini Bagavant; Umesh S Deshmukh
Journal:  Ann Rheum Dis       Date:  2015-02-05       Impact factor: 19.103

3.  Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.

Authors:  S-R Nandula; Y M Scindia; P Dey; H Bagavant; U S Deshmukh
Journal:  Oral Dis       Date:  2011-08-04       Impact factor: 3.511

Review 4.  Pathogenesis of Sjögren's syndrome.

Authors:  Nikolay P Nikolov; Gabor G Illei
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 5.  Sjögren syndrome: advances in the pathogenesis from animal models.

Authors:  J A Chiorini; D Cihakova; C E Ouellette; P Caturegli
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

6.  Current Aspects of Pathogenesis in Sjögren's Syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 7.  Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

Authors:  Jing Li; Xiaohui Wang; Fengchun Zhang; Hang Yin
Journal:  Pharmacol Ther       Date:  2013-03-24       Impact factor: 12.310

8.  Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.

Authors:  N C Kyriakidis; E K Kapsogeorgou; V C Gourzi; O D Konsta; G E Baltatzis; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

9.  Type I interferon receptor deficiency prevents murine Sjogren's syndrome.

Authors:  B M Szczerba; P D Rybakowska; P Dey; K M Payerhin; A B Peck; H Bagavant; U S Deshmukh
Journal:  J Dent Res       Date:  2013-03-26       Impact factor: 6.116

10.  Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.

Authors:  Jing Zhou; Jun-O Jin; Juan Du; Qing Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.